Skip to content

Gufic Biosciences gains on Aussie, Brazilian nod to pain-killer drug

“The medicine will be used for short-term treatment of acute pain and post-operative pain in adult patients,â€� the company said in a regulatory filing at the exchanges.

Read More

​ “The medicine will be used for short-term treatment of acute pain and post-operative pain in adult patients,â€� the company said in a regulatory filing at the exchanges. “The medicine will be used for short-term treatment of acute pain and post-operative pain in adult patients,â€� the company said in a regulatory filing at the exchanges.  Moneycontrol Latest News Read More  

Leave a Reply

Your email address will not be published. Required fields are marked *

en_USEnglish